GCCGCC· Updated

Pharmaceutical Licence Renewals in the GCC: Products, Establishments, GMP and Pharmacists

What pharma manufacturers, importers, distributors and pharmacies renew across the GCC: marketing authorisations, establishment licences, GMP certificates and professional licences.

Pharmaceutical and medical device companies in the Gulf renew at four levels: the product (marketing authorisation or registration), the establishment (factory, warehouse, scientific office or pharmacy licence), the manufacturing site (GMP certificates, often from overseas plants), and the people (pharmacist licences and named responsible persons). Each GCC country runs its own registrations, and a lapse at any level can stop a product from being imported, sold or dispensed.

This guide maps pharmaceutical licence renewals across the GCC and shows how to keep a portfolio of products and sites in view.

Who regulates medicines and devices in each GCC country?

Pharmaceutical regulators in the GCC

ItemIssued byRenewal cycle

Saudi medicines, devices and establishments

Saudi Food and Drug Authority (SFDA)Time-limited registrations and licences

UAE federal product registration

MOHAP / Emirates Drug EstablishmentTime-limited registrations

Pharmacies and pharmacists in Dubai and Abu Dhabi

DHA (Dubai), DoH (Abu Dhabi)Per facility and professional licence

Qatar medicines and pharmacies

Ministry of Public HealthPer registration and licence

Bahrain medicines and pharmacies

National Health Regulatory Authority (NHRA)Per registration and licence

Kuwait and Oman

Ministry of Health in each countryPer registration and licence
Main medicines regulators; emirate health authorities in the UAE license pharmacies and staff.

In the UAE, federal medicines regulation has been moving from the Ministry of Health and Prevention (MOHAP) to the Emirates Drug Establishment, created to take over that role. Check which body handles your product category before you file. Across the region, the Gulf Health Council also runs a centralised GCC registration route that some companies use alongside national registrations.

Product registrations and marketing authorisations

Every medicine sold in a GCC country needs a registration in that country, and the registration is not permanent. Expect:

  • Renewal on a fixed multi-year cycle, with the dossier, prices and labelling confirmed at each renewal.
  • Variations for changes to the manufacturing site, formulation, pack or labelling, which must be approved before the change is implemented.
  • Pricing approvals that some regulators review separately from the registration.
  • Medical device registrations, such as SFDA's Medical Device Marketing Authorization (MDMA), which often depend on the device's CE or FDA status staying valid.

A company with 200 products registered in three countries is managing 600 registration dates, before variations. That is the main reason pharma regulatory teams outgrow spreadsheets.

Establishment licences: factories, warehouses, scientific offices and pharmacies

The premises that make, store and sell medicines are licensed separately from the products:

  • Manufacturing licences for local factories, issued by SFDA in Saudi Arabia and by the federal regulator in the UAE, with GMP inspections as a condition.
  • Drug store and warehouse licences, which require Good Distribution and Storage Practice, temperature mapping and calibrated monitoring.
  • Scientific office or marketing authorisation holder registrations for foreign manufacturers' local representatives.
  • Pharmacy licences from DHA, DoH, SFDA or the relevant ministry, renewed alongside the commercial licence.
  • Controlled and narcotic drug permits, which have their own records and inspection regime.

GMP certificates and overseas sites

Most medicines sold in the Gulf are made elsewhere, so GCC regulators rely on evidence that the overseas plant meets GMP. That creates dates you do not control:

  • GMP certificates issued by the plant's home regulator or by a GCC inspection, each with an expiry date.
  • Certificates of Pharmaceutical Product (CPP) and free sale certificates, needed for registration and renewal, which must be current and often legalised.
  • Third-party contract manufacturers whose GMP status underpins your registration.

If a supplying site's GMP certificate lapses, the products made there can face suspension until new evidence is accepted. Track each manufacturing site as its own item, linked to the products it supplies.

What a single medicine depends on in the GCC

Product

SFDA, UAE federal regulator, national ministries

  • Registration in each country
  • Approved variations
  • Price approval

Site

Home regulator or GCC inspection

  • GMP certificate
  • CPP or free sale certificate

Establishment

Medicines regulator, municipality

  • Warehouse or drug store licence
  • Commercial licence

People

SCFHS, DHA, DoH and others

  • Pharmacist licences
  • Responsible person and pharmacovigilance officer
A lapse at any level can stop supply.

Pharmacists, responsible persons and pharmacovigilance

Licensing bodies expect named, licensed people in key roles:

  • Pharmacist licences from the Saudi Commission for Health Specialties (SCFHS), DHA, DoH, NHRA or the relevant ministry, renewed periodically with continuing education credits.
  • Responsible pharmacists for each pharmacy, warehouse or factory. If that person leaves, the establishment licence may need updating.
  • Qualified person for pharmacovigilance for marketing authorisation holders, with safety reports (PSURs) due on a schedule.
  • Good Distribution Practice and cold chain training for warehouse staff, refreshed periodically.

Planning lead times for pharma renewals

Pharmaceutical renewals take longer than commercial ones because the paperwork often starts outside the Gulf. A workable plan:

  • 12 months ahead of a product registration expiry: check whether the dossier needs updating and whether any variations are pending.
  • 6 to 9 months ahead: request a current CPP, GMP evidence and any legalised documents from the manufacturer. Embassy legalisation and translation can take weeks on their own.
  • 3 to 6 months ahead: submit the renewal, following the regulator's published submission window for your product type.
  • 90 days ahead of an establishment licence: confirm the responsible pharmacist's licence, warehouse temperature mapping and calibration certificates are current.

Regulators publish their own submission windows, and some will not accept a renewal too early or too late. Use their guidance, then build your internal deadlines in front of it.

What happens when something lapses

Consequences depend on the item. An expired product registration means the product cannot legally be imported or sold until it is renewed or re-registered. An expired establishment licence can close the warehouse or pharmacy. A pharmacist working on an expired licence exposes both the person and the employer to penalties. Health regulators in the region inspect regularly and take licensing seriously, so a margin of several months on product and GMP renewals is normal practice.

How RenewalDesk supports pharma regulatory teams

RenewalDesk is a renewal tracker, not a regulatory information management system. It does not hold dossiers or submit to SFDA or any other regulator. What it does well is make sure no date in the portfolio is missed:

  • Every registration, licence and certificate in one list, grouped by legal entity or country, with the current certificate attached.
  • Early reminders by email and in-app. The default schedule is 90, 60, 30, 14, 7 and 1 days before expiry; set a custom schedule starting much earlier for product renewals and GMP certificates.
  • Renewal workflow. Assign each renewal to a regulatory officer, track steps such as legalising a CPP or updating the dossier, and record the new expiry date when approved.
  • Audit trail and exports of every change, useful for internal audit and inspections.
  • Bulk import of an existing registration register from Excel or CSV.
RenewalDesk renewal report ready to export
Reports export to Excel or CSV for audits and client updates.

For the global picture, see compliance renewals for pharmaceutical and life sciences companies. Pharmacy groups and hospitals should also read healthcare licence renewals in Saudi Arabia and healthcare licensing in the UAE. All features are listed on the features page.

Frequently asked questions

Who registers medicines in Saudi Arabia?

The Saudi Food and Drug Authority (SFDA) registers medicines and medical devices and licenses pharmaceutical factories, warehouses and other establishments. Registrations are time-limited and must be renewed, with the dossier and labelling kept current.

Who regulates pharmaceuticals in the UAE?

Federal product registration has been handled by the Ministry of Health and Prevention (MOHAP) and is moving to the Emirates Drug Establishment. Pharmacies and pharmacists are licensed by the emirate health authority, such as the DHA in Dubai and the DoH in Abu Dhabi, or by MOHAP in the other emirates.

Do GMP certificates expire?

Yes. GMP certificates are issued for a limited period after an inspection, and GCC regulators expect current GMP evidence for each manufacturing site supplying registered products. Track each site's certificate and request renewed evidence before it expires.

Is there a single GCC registration for medicines?

The Gulf Health Council operates a centralised registration route for GCC member states, but national registration and marketing requirements still apply. Many companies track both the centralised and the national registrations.

Pharmaceutical regulation in the GCC is evolving, including changes to regulators and procedures. Confirm current requirements with the relevant authority before you renew.

Start tracking renewals today

Put every license, contract, and certificate in one place — and get reminded before anything expires.

Start free trial

More articles